294
Fatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62-year-old woman who received six cycles of paclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer.
 62-year-old woman: Subject; advanced ovarian cancer: Subject; 62-year-old: Subject.Age; woman: Subject.Gender; Fatal lung fibrosis: Effect; six cycles of paclitaxel and carboplatin as combination chemotherapy: Treatment; six cycles: Treatment.Dosage; paclitaxel: Treatment.Drug; carboplatin: Treatment.Drug; advanced ovarian cancer: Treatment.Disorder; chemotherapy: Treatment.Route; paclitaxel: Combination.Drug; carboplatin: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 62-year-old woman: Subject; advanced ovarian cancer: Subject; 62-year-old: Subject.Age; woman: Subject.Gender; Fatal lung fibrosis: Effect; six cycles of paclitaxel and carboplatin as combination chemotherapy: Treatment; six cycles: Treatment.Dosage; paclitaxel: Treatment.Drug; carboplatin: Treatment.Drug; advanced ovarian cancer: Treatment.Disorder; chemotherapy: Treatment.Route; paclitaxel: Combination.Drug; carboplatin: Combination.Drug